Hello everyone. If you’re seeing this, then most likely you’ve been reading my article on Seeking Alpha about the impact of Breakthrough Therapy designation on the time to a drug’s first approval. As I have with other big articles, I want to offer a place where people can come and get the spreadsheet so they can play with the numbers and view in a more palatable format.
Thank you very much for reading! If you enjoyed this article, I hope you’ll consider checking out the rest of Invest Against Cancer, including articles giving a rundown on therapies like sacituzumab govitecan, as well as articles guiding you on what to avoid with cancer penny stocks.
Also, if you’re interested in seeing how I would consider trading these developmental biotech companies, feel free to check out my book about the No BS Plan, which can help you avoid losses through a regimented, disciplined strategy. It’s available both in E-book format and paperback editions!
Click here to check out The No BS Plan on Amazon. (note: contains affiliate link)